3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
7
Terminated
4
Withdrawn
1
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Nasopharyngeal Carcinoma
20
Squamous Cell Carcinoma of Head and Neck
7
Oropharyngeal Neoplasms
7
Prostatic Neoplasms
5
Carcinoma
4
Rectal Neoplasms
3
Nasopharyngeal Neoplasms
3
Mouth Neoplasms
3
Laryngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Head and Neck Neoplasms
3
Carcinoma, Squamous Cell
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Stomatitis
2
Pancreatic Adenocarcinoma
2
Neoplasm Metastasis
2
Meningeal Carcinomatosis
2
Lung Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Endometrial Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Tumor Virus Infections
1
Thyroid Carcinoma, Anaplastic
1
Stomatognathic Diseases
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Sarcoma
1
Recurrence
1
Interventions
Gemcitabine
56
130-nm albumin-bound paclitaxel
31
Magnetic Resonance Spectroscopy
22
Taxes
18
Specimen Handling
18
Albumin-Bound Paclitaxel
18
Fluorouracil
17
Drug Therapy
17
Oxaliplatin
16
Leucovorin
16
pembrolizumab
15
Irinotecan
14
Biopsy
12
Cyclophosphamide
11
Blood Specimen Collection
11
fludarabine
10
Radiosurgery
9
irinotecan sucrosofate
8
Cetuximab
7
olaparib
6
folfirinox
6
Magnetic Resonance Imaging
6
Cisplatin
6
Bevacizumab
6
dehydroftorafur
5
Surveys and Questionnaires
5
Nivolumab
5
Endoscopic Ultrasound-Guided Fine Needle Aspiration
5
Capecitabine
5
sintilimab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Pancreatic Neoplasms
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT06249321
2025-08-07
PTCA199-10
Fudan University
Phase 2
Recruiting
30 enrolled